India's New Drug Rules: Will Pharma Companies Keep Up?

India's New Drug Rules: Will Pharma Companies Keep Up?

Big changes are coming to India’s pharmaceutical industry! 💊

Are drug companies ready to meet the new standards?

In this episode of Pharma Tales, we break down the latest update on India’s revised Schedule M regulations, which demand stricter quality control and upgraded manufacturing facilities across the country. While the goal is to ensure safer, high-quality medicines, many small and medium-sized pharma companies are lagging behind—and the Health Ministry is getting involved.

🧪 What is Schedule M and why does it matter?

🏭 Why haven’t some companies complied yet?
👨‍⚕️ How will this impact medicine quality, availability, and costs in India?
If you’re interested in pharma news, drug safety, or regulatory updates, this video is a must-watch.

📢 Don’t forget to LIKE, COMMENT, and SUBSCRIBE to Pharma Tales for more insights on medical breakthroughs, policy changes, and global drug trends!

#ScheduleM #IndiaPharmaNews #DrugRegulationsIndia #PharmaceuticalIndustry #MedicineQuality #PharmaTales #DrugManufacturing #HealthMinistryIndia #PharmaCompliance #IndianDrugRules #GMPIndia #MedicineSafetyIndia #PharmaUpdates #PharmaPolicy #DrugCompanyNews